Target Price | $11.22 |
Price | $2.78 |
Potential |
303.60%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target EyeGate Pharmaceuticals, Inc. 2026 .
The average EyeGate Pharmaceuticals, Inc. target price is $11.22.
This is
303.60%
register free of charge
$12.60
353.24%
register free of charge
$10.10
263.31%
register free of charge
|
|
A rating was issued by 8 analysts: 7 Analysts recommend EyeGate Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the EyeGate Pharmaceuticals, Inc. stock has an average upside potential 2026 of
303.60%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.87 | -2.46 |
132.34% | 382.76% | |
P/E | negative | |
EV/Sales | negative |
4 Analysts have issued a EyeGate Pharmaceuticals, Inc. forecast for earnings per share. The average EyeGate Pharmaceuticals, Inc. EPS is
This results in the following potential growth metrics and future valuations:
EyeGate Pharmaceuticals, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 12 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.